Stellate ganglion block with bupivacaine.

Plasma concentrations of bupivacaine after stellate ganglion block using two volumes of 0.25% bupivacaine plain solution.

Plasma concentrations of bupivacaine were measured in patients after stellate ganglion block using either 10 or 20 ml of 0.25% plain solution. The mean peak concentrations were greater in the larger volume group, but this was not statistically significant. From 30 min after injection, there was a significantly greater plasma concentration in the larger volume group. The concentrations approache...

Seborrheic dermatitis treatment with stellate ganglion block

disorder characterized by hyperkeratosis, acanthosis, accentuated rete ridges, focal spongiosis, and parakeratosis. It is usually caused by increased sebaceous gland activity, and manifests itself through the apparition of ill-defined eryhematous patches accompanied by fine scaling in areas of high sebum secretion, including the scalp, face, eyebrows, nasal alar creases, melolabial folds, ears,...

Stellate ganglion block in glaucoma.

Severe hypertension after stellate ganglion block.

Haemodynamic effects may occur after stellate ganglion block (SGB) arising from autonomic imbalance and local anaesthetic infiltration to barosensitive areas. We report seven patients who developed severe hypertension (systolic arterial pressure >200 mm Hg) after SGB in our pain clinic service. We postulate that diffusion of the local anaesthetic along the carotid sheath may produce vagal block...

Thalamic pain alleviated by stellate ganglion block

RATIONALE Thalamic pain is a distressing and treatment-resistant type of central post-stroke pain. Although stellate ganglion block is an established intervention used in pain management, its use in the treatment of thalamic pain has never been reported. PATIENT CONCERNS A 66-year-old woman presented with a 3-year history of severe intermittent lancinating pain on the right side of the face a...